Moderna stock has reached day 5 of a consecutive winning streak, with total gains during this time reaching a 13% return.

The S&P 500 Healthcare sector (XLV) experienced a slight rise in average short interest during October, moving from 1.91% to ...

New research found that mRNA vaccines for COVID-19 could enhance cancer treatments and help patients live longer.

Q3 earnings beat estimates but pipeline setback and lower 2025 guidance raise concerns. Full analysis of results and outlook.

A claque of online anti-vaccine influencers and dissentient researchers are claiming that COVID-19 vaccines are causing an ...

There's a new frontier in treating autoimmune diseases. Today's treatments tamp down the friendly fire but don't fix what's ...

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

A new mRNA platform targets tumors with precision, limits side effects, and converts immune-silent cancers into responsive ones for stronger treatment outcomes.

Biotechnology company Moderna (NASDAQ:MRNA) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell ...

Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting ...

Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE , more than five years after both ...